Table 1 Demographic and clinical characteristics of VRFC and AIS patients

Age, years, mean (SD)

64.65 (8.59)

67.02 (7.72)

0.175

Gender, male, n/N (%)

10/20 (50%)

42/62 (67.7%)

0.182

Smoker, n/N (%)

7/20 (35%)

33/62 (53.2%)

0.389

Drinker, n/N (%)

3/20 (15%)

19/62 (30.6%)

0.931

Hypertension, n/N (%)

12/20 (60%)

46/62 (74.2%)

0.691

Diabetes mellitus, n/N (%)

9/20 (45%)

26/62 (41.9%)

0.581

Stroke severity (NIHSS)

      Mild (0–4), n/N (%)

–

21/62 (33.9%)

–

      Moderate (5–15), n/N (%)

–

41/62 (66.1%)

–

Triglyceride, medium (IQR)

1.33 (0.96–1.7)

1.45 (0.97–2.09)

0.262

Total cholesterol, mean (SD)

4.57 (1.54)

4.91 (1.23)

0.524

HDL-C, mean (SD)

1.25 (0.33)

1.16 (0.25)

0.906

LDL-C, mean (SD)

2.5 (1.12)

2.79 (0.8)

0.430

WBC, mean (SD)

6.18 (0.93)

6.69 (1.42)

0.244

Neutrophils, mean (SD)

3.93 (0.83)

4.32 (1.16)

0.274

Lymphocytes, medium (IQR)

1.78 (1.36–2.2)

1.73 (1.3–2.41)

0.273

Monocytes, medium (IQR)

0.37 (0.29–0.43)

0.34 (0.27–0.44)

0.407